Senate Bill 3049
116th Congress(2019-2020)
LAB Act
Introduced
Introduced in Senate on Dec 12, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3049
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Laboratory Access for Beneficiaries Act or the LAB Act
This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services for purposes of determining Medicare payment rates. Additionally, the Medicare Payment Advisory Commission must evaluate the methodology used to determine a specified laboratory fee schedule.
December 12, 2019
12/12/2019
Read twice and referred to the Committee on Finance.
12/12/2019
Introduced in Senate
Public Record
Record Updated
Oct 28, 2022 1:45:57 AM